Status:
RECRUITING
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
Lead Sponsor:
Beijing University of Chinese Medicine
Collaborating Sponsors:
The University of Science and Technology of China
China Academy of Chinese Medical Sciences
Conditions:
Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation
Eligibility:
All Genders
18-75 years
Brief Summary
Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to developed risk assessment and syndrome evolution models of CAG malignant tr...
Detailed Description
Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). Active treatment of CAG is vital in arresting malignant transformation. Traditional Chinese medicine ...
Eligibility Criteria
Inclusion
- (1) 18-75 years of age; (2) Meeting diagnostic criteria of CAG after upper gastrointestinal endoscopy; (3) Willing to cooperate with data, tissue sample, and blood sample collection during recruitment; (4) Willing to respond truthfully and timely to researcher queries after recruitment, able to cooperate with data, tissue sample and blood sample collection during follow-ups; (5) Willing to sign informed consent.
Exclusion
- (1) Meeting past history of previous stomach surgery; (2) Unable to participate in data, tissue sample or blood sample collection for any reason.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03261934
Start Date
January 1 2018
End Date
December 31 2030
Last Update
December 29 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongzhimen Hospital
Beijing, Beijing Municipality, China, 100029
2
Wangjing Hospital
Beijing, Beijing Municipality, China, 100102